IKBKE-AS1
Putative uncharacterized protein IKBKE-AS1
Also known as: CA147_HUMAN
Protein identityUniProt · HPA
OverviewNCBI Gene
No narrative summary is available for IKBKE-AS1 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
270 residues, UniProt reviewed canonical sequence.
>Q96MC9|IKBKE-AS1
1 MQGNNLQPPS PRPLECWSLH REAPQRTEAS RTHPSPFLAL PGSHRTANQA QVVPGLVHHP
61 QENTQRLRIR AGLSPFPRAR LAAIGSTHGH RWVPGICLPR CLCPASCALH ACPPHCNNAE
121 AHSWLRLGGP LQSRSVEHQQ HACGWGWVTH ATYGERGTSQ AAERQRIAHT RALSVGNCPR
181 SHFQCEFSSI SKWSEGTGTF SPRPRAVKSG VGGQPSPHIR ITWRSCTTLT SKPCSRAITP
241 ECVVGWSRRS RHWYSDMRTG ECQGLSPITRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against IKBKE-AS1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.6
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads IKBKE-AS1 as an antibody target. Whether an autoantibody or antibody against IKBKE-AS1 could matter depends on whether native IKBKE-AS1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
IKBKE-AS1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label IKBKE-AS1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...